Bicocca Open Archive

Logo unimib boa
SERAVALLE, GINO LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.624
AS - Asia 3.023
EU - Europa 2.667
SA - Sud America 517
AF - Africa 59
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.907
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.521
SG - Singapore 1.227
CN - Cina 703
HK - Hong Kong 571
RU - Federazione Russa 562
DE - Germania 540
BR - Brasile 406
IT - Italia 366
IE - Irlanda 324
SE - Svezia 299
VN - Vietnam 232
GB - Regno Unito 140
AT - Austria 105
UA - Ucraina 82
FR - Francia 66
CA - Canada 63
IN - India 55
ID - Indonesia 52
AR - Argentina 46
FI - Finlandia 44
KR - Corea 39
DK - Danimarca 29
MX - Messico 29
JP - Giappone 28
ZA - Sudafrica 27
EC - Ecuador 25
PL - Polonia 25
TR - Turchia 24
BD - Bangladesh 19
ES - Italia 16
NL - Olanda 16
BE - Belgio 14
CO - Colombia 11
IQ - Iraq 11
PK - Pakistan 10
CL - Cile 8
SA - Arabia Saudita 8
AU - Australia 7
UZ - Uzbekistan 7
VE - Venezuela 7
BG - Bulgaria 6
EG - Egitto 6
PE - Perù 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
MK - Macedonia 5
PY - Paraguay 5
SN - Senegal 5
EU - Europa 4
IR - Iran 4
LT - Lituania 4
NZ - Nuova Zelanda 4
CH - Svizzera 3
DZ - Algeria 3
LK - Sri Lanka 3
MA - Marocco 3
NG - Nigeria 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
BH - Bahrain 2
BJ - Benin 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
MU - Mauritius 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.907
Salva come PNG Salva come JPEG
Città #
Ann Arbor 877
Singapore 683
Hong Kong 567
Fairfield 495
Ashburn 452
Frankfurt am Main 402
Chandler 316
Dublin 313
Wilmington 257
Woodbridge 221
Houston 213
Seattle 208
New York 193
Dallas 172
Dearborn 139
Milan 131
Princeton 130
Beijing 126
Cambridge 124
Santa Clara 103
Vienna 96
Los Angeles 90
Hefei 81
Moscow 75
Jacksonville 72
Ho Chi Minh City 68
Altamura 58
Lawrence 56
Nanjing 49
The Dalles 45
Shanghai 44
Buffalo 42
Hanoi 39
São Paulo 38
Chicago 36
Jakarta 35
Seoul 34
Dong Ket 33
San Diego 33
Council Bluffs 31
Munich 30
London 24
Lissone 23
Guangzhou 21
Boardman 20
Helsinki 20
Andover 19
Atlanta 19
Salt Lake City 19
Tokyo 19
Toronto 19
Nanchang 17
Warsaw 17
Montreal 16
Kunming 15
Brooklyn 14
Jiaxing 13
Shenyang 13
Brussels 12
Changsha 12
Columbus 12
Poplar 12
San Francisco 12
Tianjin 12
Belo Horizonte 11
Haiphong 11
Rio de Janeiro 11
Jinan 10
Orem 10
Quito 10
Hebei 9
Nuremberg 9
Phoenix 9
Da Nang 8
Denver 8
Falls Church 8
Johannesburg 8
Lappeenranta 8
Mumbai 8
Turku 8
Bexley 7
Brasília 7
Edmonton 7
Hangzhou 7
Lachine 7
Monza 7
Pune 7
Sacramento 7
Stockholm 7
Tashkent 7
Bologna 6
Bonndorf 6
Chennai 6
Concorezzo 6
Copenhagen 6
Düsseldorf 6
Esslingen am Neckar 6
Mexico City 6
Norwalk 6
Quận Bình Thạnh 6
Totale 7.863
Salva come PNG Salva come JPEG
Nome #
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 296
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 282
Heart rate as cardiovascular risk factor 279
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 268
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 246
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 239
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 238
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 236
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 236
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 233
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights 228
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 222
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 219
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 213
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 208
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 205
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 199
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 196
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 195
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 194
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 191
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 186
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome 175
Effects of Renal Denervation on Sympathetic Nervous System Activity 169
The role of carotid baroreceptor stimulation 165
Baroreflex activation therapy systems: current status and future prospects 165
Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications 162
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 158
The role of brain in neurogenic prehypertension 153
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 151
Blood pressure measurement, white-coat and masked hypertension 150
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 149
Age- and sex-specific reference values for media/lumen ratio in small arteries and relationship with risk factors 147
Sympatho-Vagal Imbalance in Hypertension 147
Sympathetic Nervous System, Sleep, and Hypertension 142
Elevated heart rate as sympathetic biomarker in human obesity 138
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 138
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 138
Obesity and Hypertension 135
Heart rate as a predictor of cardiovascular risk 134
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 134
Obesity and hypertension 132
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS) 128
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 128
Assessment of heart rate as 'sympathetic biomarker': Strengths and pitfalls 128
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 128
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 126
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 123
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction 122
Treatment of resistant hypertension 122
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 121
Lercanidipine in the management of hypertension: An update 120
New-onset aortic dilatation in the population: a quarter-century follow-up 118
Sleep Apnea and Hypertension 116
Cigarette smoking and the adrenergic nervous system 115
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea 114
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension 113
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study 111
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 110
Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment 109
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE 109
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 107
Cardiovascular physiology: regulation of blood pressure 104
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 104
Neurohormonal interactions 104
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans 104
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 103
Neural Mechanisms 103
Arterial alterations in hypertension 99
Device-Based Treatment in Hypertension and Heart Failure 96
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes 95
Clinical relevance of the sympathetic–vascular interactions in health and disease 95
Sympathetic Activity in Hypertension and Heart Failure 93
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 92
Corrigendum to “Obesity and hypertension” [Pharmacological Research 122 (2017) 1–7](S1043661817304620)(10.1016/j.phrs.2017.05.013) 89
Microvascular Alterations in Obesity 87
Baroreceptor Stimulation 87
Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients 86
Trained Athletes 83
Sympathomodulation in congestive heart failure: From drugs to devices 81
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload 78
The sympathetic nervous system in hypertension 70
ASSOCIATION BETWEEN HEART RATE TRESHOLDS FOR CARDIOVASCULAR RISK DEFINED BY NEW ESC/ESH GUIDELINES AND NEUROADRENERGIC MARKERS 64
Totale 12.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021870 0 0 0 0 0 108 160 158 116 115 87 126
2021/2022970 81 87 106 57 75 64 64 56 41 89 77 173
2022/20231.521 169 421 170 135 96 250 28 66 100 17 48 21
2023/20241.082 30 34 46 107 155 278 173 25 100 17 16 101
2024/20252.531 150 318 112 92 196 97 169 107 242 372 269 407
2025/20262.873 519 310 489 665 653 237 0 0 0 0 0 0
Totale 12.276